Mesenchymal Stem Cells Market Size, Growth, Trends and Forecast 2023-2028

 The latest report by IMARC Group, titled “Mesenchymal Stem Cells Market by Product & Services (Products, Services), Type (Autologous, Allogeneic), Source of Isolation (Bone Marrow, Cord Blood, Peripheral Blood, Fallopian Tube, Fetal Liver, Lung, Adipose Tissues), Indication (Bone and Cartilage Repair, Cardiovascular Disease, Inflammatory and Immunological Diseases, Liver Diseases, Cancer, GvHD, and Others), Application (Disease Modelling, Drug Development and Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies), and Region 2023-2028“, The global mesenchymal stem cells market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.16 Billion by 2028, exhibiting a growth rate (CAGR) of 13.06% during 2023-2028.

Factors Affecting the Growth of the Global Mesenchymal Stem Cells Industry:

• Increasing Research and Developmental Activities:

The escalating number of research projects and clinical trials involving MSCs is a primary driver for the market. Scientists and researchers are continuously exploring the potential of MSCs in treating various medical conditions, including autoimmune diseases, orthopedic injuries, and cardiovascular diseases. This surge in research activities is fueled by MSCs' unique ability to differentiate into various cell types and their anti-inflammatory and immunomodulatory properties. As a result, there is an increasing investment in R&D by biotechnology companies and academic institutions, contributing to the expansion of the MSC market.

• Rising Demand for Regenerative Medicine:

Regenerative medicine, aiming to restore the structure and function of damaged tissues and organs, is increasingly adopting MSC therapies. MSCs are crucial in this domain due to their ability to differentiate into a variety of cell types, such as bone, cartilage, muscle, and fat cells. Their capacity to modulate the immune system and promote tissue repair makes them ideal for regenerative therapies. With an aging global population and a rise in chronic diseases, the demand for effective regenerative treatments is growing, subsequently driving the MSC market forward.

• Technological Advancements:

Technological advancements in biotechnology are significantly contributing to the growth of the MSC market. Improved methods for the isolation, culture, and expansion of MSCs have enhanced their viability and therapeutic potential. Additionally, advancements in genetic engineering, cell processing technologies, and 3D bioprinting are opening new avenues for MSC applications. These technological improvements not only enhance the effectiveness of MSC-based therapies but also increase their accessibility and affordability, thereby bolstering market growth.

Competitive Landscape with Key Player:

• ATCC
• Axol Bioscience Ltd.
• Cell Applications Inc.
• Celprogen Inc.
• Cyagen Biosciences Inc.
• Lonza Group AG
• Merck KGaA
• PromoCell GmbH
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/mesenchymal-stem-cells-market

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product & Services:

• Products
  • Cells and Cell Lines
  • Kits, Media, and Reagents
  • Others
• Services

Products represents the largest segment due to the rising need for a consistent and reliable supply of MSCs and MSC-derived products.

Breakup by Type:

• Autologous
• Allogeneic

Allogenic holds the largest market share as it eliminates the need for invasive and time-consuming procedures.

Breakup by Source of Isolation:

• Bone Marrow
• Cord Blood
• Peripheral Blood
• Fallopian Tube
• Fetal Liver
• Lung
• Adipose Tissues

Bone marrow represents the largest segment as it possess unique regenerative properties, making it an attractive option for treating various conditions.

Breakup by Indication:

• Bone and Cartilage Repair
• Cardiovascular Disease
• Inflammatory and Immunological Diseases
• Liver Diseases
• Cancer
• GvHD
• Others

Cardiovascular disease accounted for the largest market share due to the growing prevalence of heart failure, ischemic heart disease, and myocardial infarction.

Breakup by Application:

• Disease Modelling
• Drug Development and Discovery
• Stem Cell Banking
• Tissue Engineering
• Toxicology Studies

Disease modelling represents the largest segment due to the growing interest and investments in the field of regenerative medicine and cell-based therapies.

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America leads the market as it has well-established healthcare infrastructure and rising geriatric population.

Mesenchymal Stem Cells Market Trends:

Manufacturers are focusing on improving the scalability and cost-effectiveness of MSC production. This includes developing more efficient production processes and standardized protocols. Besides, personalized medicine approaches are gaining ground in the MSC market, tailoring treatments to individual patients based on their specific needs and genetic profiles. Moreover, the MSC market is expanding beyond traditional therapeutic applications. It is being explored for cosmetic and anti-aging treatments, as well as in veterinary medicine. Additionally, the number and diversity of clinical trials involving MSCs are increasing. Researchers are exploring different delivery methods, dosages, and combinations with other therapies to maximize effectiveness.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163